Dr. Randall has a 30-year history of research, leadership and service in the alcohol field. She is nationally recognized in two areas of research, one basic science and one clinical. Her current focus is on comorbid social anxiety and alcohol use. She is the Principal Investigator (PI) of an NIAAA funded study investigating the use of paroxetine for social anxiety and alcoholism.

She also has a national reputation for her pioneering research in the area of animal models of Fetal Alcohol Syndrome. She received the 1998 Distinguished Research Award from the Research Society on Alcoholism, is a recipient of the Henry Rosett Award for her contribution to Fetal Alcohol Syndrome research, and received the NIAAA Mark Keller Honorary Lecture Award for lifetime contributions to alcohol research.

With regard to alcohol treatment research, she is Co-PI with Dr. Anton in the NIAAA-multicenter clinical trial referred to as the COMBINE Study, a trial investigating the interaction of pharmacotherapy and behavioral therapy for alcoholism. Prior to these efforts in treatment outcome research, she served as PI for Project MATCH, the NIAAA-sponsored multi-site clinical research trial that evaluated the effects of treatment matching on outcome.

Her research-to-practice experience is provided by her involvement with the NIDA-sponsored Clinical Trials Network (CTN), where she serves as Co-I of the South Carolina Node. She also maintains scientific involvement in the area of alcohol and women through her Co-Directorship, with Dr. Brady, of the Women's Research Center, funded under a SCOR grant from the Office of Women's Research and NIDA to study gender differences in relapse.

Finally, she is a tireless mentor for developing alcohol researchers. She is a past director of T32 training grants and received an NIAAA-supported K24 mentoring award to help develop the next generation of clinical alcohol researchers.